Beneficial Effect of Intestinal Fermentation of Natural
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Study of the Impact of Mazie SBE I on the [Alpha]-Polyglucan Produced in Synechocystis Sp
Iowa State University Capstones, Theses and Retrospective Theses and Dissertations Dissertations 2007 A study of the impact of mazie SBE I on the [alpha]- polyglucan produced in Synechocystis sp. strain PCC 6803 Shayani Deborah Nesaranjani Pieris Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/rtd Part of the Plant Biology Commons Recommended Citation Pieris, Shayani Deborah Nesaranjani, "A study of the impact of mazie SBE I on the [alpha]-polyglucan produced in Synechocystis sp. strain PCC 6803" (2007). Retrospective Theses and Dissertations. 15850. https://lib.dr.iastate.edu/rtd/15850 This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University Digital Repository. For more information, please contact [email protected]. A study of the impact of mazie SBE I on the -polyglucan produced in Synechocystis sp. strain PCC 6803 by Shayani Deborah Nesaranjani Pieris A dissertation submitted to the graduate faculty in partial fulfillment of the requirements for the degree of DOCTOR OF PHILOSOPHY Major: Plant Physiology Program of Study Committee: Martin H. Spalding, Major Professor Madan K. Bhattacharyya Jay -lin Jane David J. Oliver Paul M. Scott Iowa State University Ames, Iowa 200 7 Copyright © Shayani Deborah Nesara njani Pieris , 200 7. All right s reserved. UMI Number: 3294976 UMI Microform 3294976 Copyright 2008 by ProQuest Information and Learning Company. All rights reserved. This microform edition is protected against unauthorized copying under Title 17, United States Code. -
Doctoral Dissertation Template
UNIVERSITY OF OKLAHOMA GRADUATE COLLEGE METAGENOMIC INSIGHTS INTO MICROBIAL COMMUNITY RESPONSES TO LONG-TERM ELEVATED CO2 A DISSERTATION SUBMITTED TO THE GRADUATE FACULTY in partial fulfillment of the requirements for the Degree of DOCTOR OF PHILOSOPHY By QICHAO TU Norman, Oklahoma 2014 METAGENOMIC INSIGHTS INTO MICROBIAL COMMUNITY RESPONSES TO LONG-TERM ELEVATED CO2 A DISSERTATION APPROVED FOR THE DEPARTMENT OF MICROBIOLOGY AND PLANT BIOLOGY BY ______________________________ Dr. Jizhong Zhou, Chair ______________________________ Dr. Meijun Zhu ______________________________ Dr. Fengxia (Felicia) Qi ______________________________ Dr. Michael McInerney ______________________________ Dr. Bradley Stevenson © Copyright by QICHAO TU 2014 All Rights Reserved. Acknowledgements At this special moment approaching the last stage for this degree, I would like to express my gratitude to all the people who encouraged me and helped me out through the past years. Dr. Jizhong Zhou, my advisor, is no doubt the most influential and helpful person in pursuing my academic goals. In addition to continuous financial support for the past six years, he is the person who led me into the field of environmental microbiology, from a background of bioinformatics and plant molecular biology. I really appreciated the vast training I received from the many interesting projects I got involved in, without which I would hardly develop my broad experienced background from pure culture microbial genomics to complex metagenomics. Dr. Zhili He, who played a role as my second advisor, is also the person I would like to thank most. Without his help, I could be still struggling working on those manuscripts lying in my hard drive. I definitely learned a lot from him in organizing massed results into logical scientific work—skills that will benefit me for life. -
Consolidated Version of the Sanpin 2.3.2.1078-01 on Food, Raw Material, and Foodstuff
Registered with the Ministry of Justice of the RF, March 22, 2002 No. 3326 MINISTRY OF HEALTH OF THE RUSSIAN FEDERATION CHIEF STATE SANITARY INSPECTOR OF THE RUSSIAN FEDERATION RESOLUTION No. 36 November 14, 2001 ON ENACTMENT OF SANITARY RULES (as amended by Amendments No.1, approved by Resolution No. 27 of Chief State Sanitary Inspector of the RF dated 20.08.2002, Amendments and Additions No. 2, approved by Resolution No. 41 of Chief State Sanitary Inspector of the RF dated15.04.2003, No. 5, approved by Resolution No. 42 of Chief State Sanitary Inspector of the RF dated 25.06.2007, No. 6, approved by Resolution No. 13 of Chief State Sanitary Inspector of the RF dated 18.02.2008, No. 7, approved by Resolution No. 17 of Chief State Sanitary Inspector of the RF dated 05.03.2008, No. 8, approved by Resolution No. 26 of Chief State Sanitary Inspector of the RF dated 21.04.2008, No. 9, approved by Resolution No. 30 of Chief State Sanitary Inspector of the RF dated 23.05.2008, No. 10, approved by Resolution No. 43 of Chief State Sanitary Inspector of the RF dated 16.07.2008, Amendments No.11, approved by Resolution No. 56 of Chief State Sanitary Inspector of the RF dated 01.10.2008, No. 12, approved by Resolution No. 58 of Chief State Sanitary Inspector of the RF dated 10.10.2008, Amendment No. 13, approved by Resolution No. 69 of Chief State Sanitary Inspector of the RF dated 11.12.2008, Amendments No.14, approved by Resolution No. -
Shotgun Metagenomics of 361 Elderly Women Reveals Gut Microbiome
bioRxiv preprint doi: https://doi.org/10.1101/679985; this version posted June 23, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Shotgun Metagenomics of 361 elderly women reveals gut microbiome change in bone mass loss Qi Wang1,2,3,4, *, Hui Zhao1,2,3,4, *, Qiang Sun2,5, *, Xiaoping Li3,4, *, Juanjuan Chen3,4, Zhefeng Wang6, Yanmei Ju2,3,4, Zhuye Jie3,4, Ruijin Guo3,4,7,8, Yuhu Liang2, Xiaohuan Sun3,4, Haotian Zheng3,4, Tao Zhang3,4, Liang Xiao3,4, Xun Xu3,4, Huanming Yang3,9, Songlin Peng6, †, Huijue Jia3,4,7,8, †. 1. School of Future Technology, University of Chinese Academy of Sciences, Beijing, 101408, China. 2. BGI Education Center, University of Chinese Academy of Sciences, Shenzhen 518083, China; 3. BGI-Shenzhen, Shenzhen 518083, China; 4. China National Genebank, Shenzhen 518120, China; 5. Department of Statistical Sciences, University of Toronto, Toronto, Canada; 6. Department of Spine Surgery, Shenzhen People's Hospital, Ji Nan University Second College of Medicine, 518020, Shenzhen, China. 7. Macau University of Science and Technology, Taipa, Macau 999078, China; 8. Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, BGI-Shenzhen, Shenzhen 518083, China; 9. James D. Watson Institute of Genome Sciences, 310058 Hangzhou, China; * These authors have contributed equally to this study †Corresponding authors: S.P., [email protected]; H.J., [email protected]; bioRxiv preprint doi: https://doi.org/10.1101/679985; this version posted June 23, 2019. -
A Metagenomic Study of the Oral and Gut Microbiome in Crohn’S Disease Shijia Hu1* , Eileen Png2, Michelle Gowans3, David E
Hu et al. Gut Pathog (2021) 13:13 https://doi.org/10.1186/s13099-021-00409-5 Gut Pathogens RESEARCH Open Access Ectopic gut colonization: a metagenomic study of the oral and gut microbiome in Crohn’s disease Shijia Hu1* , Eileen Png2, Michelle Gowans3, David E. H. Ong3, Paola Florez de Sessions2, Jie Song2 and Niranjan Nagarajan2,4 Abstract Background: This study aims to characterize, the gut and oral microbiome in Asian subjects with Crohn’s disease (CD) using whole genome shotgun sequencing, thereby allowing for strain-level comparison. Methods: A case–control study with age, sex and ethnicity matched healthy controls was conducted. CD subjects were limited to well-controlled patients without oral manifestations. Fecal and saliva samples were collected for char- acterization of gut and oral microbiome respectively. Microbial DNA were extracted, libraries prepared and sequenced reads profled. Taxonomic diversity, taxonomic association, strain typing and microbial gene pathway analyses were conducted. Results: The study recruited 25 subjects with CD and 25 healthy controls. The oral microbe Streptococcus salivarius was found to be enriched and of concordant strains in the gut and oral microbiome of Crohn’s disease subjects. This was more likely in CD subjects with higher Crohn’s Disease Activity Index (184.3 2.9 vs 67.1 82.5, p 0.012) and active disease status (Diarrhoea/abdominal pain/blood-in-stool/fever and fatigue)± (p 0.016).± Gut species= found to be signifcantly depleted in CD compared to control (Relative abundance: Median[Range])= include: Faecalibacterium prausnitzii (0.03[0.00–4.56] vs 13.69[5.32–18.71], p 0.010), Roseburia inulinivorans (0.00[0.00–0.03] vs 0.21[0.01–0.53], p 0.010) and Alistipes senegalensis (0.00[0.00–0.00]= vs 0.00[0.00–0.02], p 0.029). -
Review Article Pullulanase: Role in Starch Hydrolysis and Potential Industrial Applications
Hindawi Publishing Corporation Enzyme Research Volume 2012, Article ID 921362, 14 pages doi:10.1155/2012/921362 Review Article Pullulanase: Role in Starch Hydrolysis and Potential Industrial Applications Siew Ling Hii,1 Joo Shun Tan,2 Tau Chuan Ling,3 and Arbakariya Bin Ariff4 1 Department of Chemical Engineering, Faculty of Engineering and Science, Universiti Tunku Abdul Rahman, 53300 Kuala Lumpur, Malaysia 2 Institute of Bioscience, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia 3 Institute of Biological Sciences, Faculty of Science, University of Malaya, 50603 Kuala Lumpur, Malaysia 4 Department of Bioprocess Technology, Faculty of Biotechnology and Biomolecular Sciences, Universiti Putra Malaysia, 43400 Serdang, Selangor, Malaysia Correspondence should be addressed to Arbakariya Bin Ariff, [email protected] Received 26 March 2012; Revised 12 June 2012; Accepted 12 June 2012 Academic Editor: Joaquim Cabral Copyright © 2012 Siew Ling Hii et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The use of pullulanase (EC 3.2.1.41) has recently been the subject of increased applications in starch-based industries especially those aimed for glucose production. Pullulanase, an important debranching enzyme, has been widely utilised to hydrolyse the α-1,6 glucosidic linkages in starch, amylopectin, pullulan, and related oligosaccharides, which enables a complete and efficient conversion of the branched polysaccharides into small fermentable sugars during saccharification process. The industrial manufacturing of glucose involves two successive enzymatic steps: liquefaction, carried out after gelatinisation by the action of α- amylase; saccharification, which results in further transformation of maltodextrins into glucose. -
Low Fructose Diet
Low Fructose Diet What is Fructose? Fructose is a naturally occurring simple sugar found in fruit, vegetables, and honey. Fructose intolerance can occur in people with irritable bowel syndrome and other GI disorders. Fruits and fruit juices with higher levels of fructose may cause gas, bloating, abdominal cramping, and diarrhea. Glucose is also a naturally occurring sugar. The more glucose than fructose in a product, the more “intestinal friendly” the fruit or fruit juice may be. High Fructose Corn Syrup (HFCS) **** HFCS is made up of almost half glucose and half fructose and may be absorbed just as well as sucrose (regular table sugar). Therefore, items with HFCS such as soft drinks, may be tolerated well when limited to 12 oz per day and with a meal. HFCS can also be found in canned, baked, or processed foods. **** In some patients, even a small amount of processed fruit juice or even foods with HFCS may cause as much malabsorption, and/or intestinal discomfort, as eating large quantities of fruit. Sorbitol Sorbitol or Sorbose is a sugar alcohol used as an artificial sweetener and found naturally in fruits and fruit juices. It can also be found in many “diet foods” such as diet soft drinks, sugarless gum, sugar-free jelly/jam, and liquid medications. Sorbitol often creates similar symptoms as fructose – especially when fructose and sorbitol are ingested together. General Guidelines • Eliminate products with ingredients that list fructose, crystalline fructose (not HFCS), honey, and sorbitol on the label. • Avoid sugar alcohols which include sorbitol, isomalt, lactitol, maltitol, mannitol, xylitol, erythrytol, and lactatol. -
Function and Structure Studies of GH Family 31 and 97 \Alpha
110610 (RV-17) Biosci. Biotechnol. Biochem., 75 (12), 110610-1–9, 2011 Award Review Function and Structure Studies of GH Family 31 and 97 -Glycosidases Masayuki OKUYAMA Research Faculty of Agriculture, Hokkaido University, Kita-9, Nishi-9, Kita-ku, Sapporo 060-8589, Japan Online Publication, December 7, 2011 [doi:10.1271/bbb.110610] A huge number of glycoside hydrolases are classified an evolutionary relationship of proteins in the family, into the glycoside hydrolase family (GH family) based from which it is often possible to extract information on on their amino-acid sequence similarity. The glycoside function and structure.3) Classification in a GH family hydrolases acting on -glucosidic linkage are in GH has, accordingly, become indispensable for research on family 4, 13, 15, 31, 63, 97, and 122. This review deals glycoside hydrolases. Glycoside hydrolases are also mainly with findings on GH family 31 and 97 enzymes. divided into two mechanistic classes, inverting and Research on two GH family 31 enzymes is described: retaining enzymes: with inversion or net retention of clarification of the substrate recognition of Escherichia anomeric configuration during the catalytic reaction.4) coli -xylosidase, and glycosynthase derived from Schiz- The stereochemical outcome is generally conserved in a osaccharomyces pombe -glucosidase. GH family 97 is GH family. The inverting mechanism proceeds via a an aberrant GH family, containing inverting and simple single displacement. Two functional groups, retainingAdvance glycoside hydrolases. The inverting View enzyme usually carboxyl groups, act as general acid and general in GH family 97 displays significant similarity to base catalysts. The general acid catalyst donates a proton retaining -glycosidases, including GH family 97 retain- to the departure aglycon, and the general base catalyst ing -glycosidase, but the inverting enzyme has no simultaneously deprotonates the incoming water mole- catalytic nucleophile residue. -
Evidence for Two Asymmetric Conformational States in the Human Erythrocyte Sugar-Transport System by JOHN E
Biochem. J. (1975) 145, 417429 417 Printed in Great Britain Evidence for Two Asymmetric Conformational States in the Human Erythrocyte Sugar-Transport System By JOHN E. G. BARNETT, GEOFFREY D. HOLMAN, R. ALAN CHALKLEY and KENNETH A. MUNDAY Department ofPhysiology and Biochlemistry, University ofSouthampton, Southampton S09 3TU, U.K. (Received 4 June 1974) 6-0-Methyl-, 6-0-propyl-, 6-0-pentyl- and 6-0-benzyl-D-galactose, and 6-0-methyl-, 6-0-propyl- and 6-0-pentyl-D-glucose inhibit the glucose-transport system of the human erythrocyte when added to the external medium. Penetration of 6-0-methyl-D-galactose is inhibited by D-glucose, suggesting that it is transported by the glucose-transport system, but the longer-chain 6-0-alkyl-D-galactoses penetrate by a slower D-glucose- insensitive route at rates proportional to their olive oil/water partition coefficients. 6-0-n-Propyl-D-glucose and 6-0-n-propyl-D-galactose do not significantly inhibit L-sorbose entry or D-glucose exit when present only on the inside of the cells whereas propyl-f6-D-glucopyranoside, which also penetrates the membrane slowly by a glucose- insensitive route, only inhibits L-sorbose entry or D-glucose exit when present inside the cells, and not when on the outside. The 6-0-alkyl-D-galactoses, like the other non- transported C4 and C-6 derivatives, maltose and 4,6-0-ethylidene-D-glucose, protect against fluorodinitrobenzene inactivation, whereas propyl ,B-D-glucopyranoside stimulates the inactivation. Of the transported sugars tested, those modified at C-1, C-2 and C-3 enhance fluorodinitrobenzene inactivation, where those modified at C-4 and C-6 do not, but are inert or protect against inactivation. -
WO 2013/116261 A2 8 August 2013 (08.08.2013) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/116261 A2 8 August 2013 (08.08.2013) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every CUD 3/386 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/US2013/023728 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, 30 January 2013 (30.01 .2013) KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (25) Filing Language: English NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, (26) Publication Language: English RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, (30) Priority Data: ZM, ZW. 12000745.5 3 February 2012 (03.02.2012) EP 12001034.3 16 February 2012 (16.02.2012) EP (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, (71) Applicant: THE PROCTER & GAMBLE COMPANY GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, [US/US]; One Procter & Gamble Plaza, Cincinnati, Ohio UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 45202 (US). -
Specific Substrate-Driven Changes in Human Faecal Microbiota Composition Contrast with Functional Redundancy in Short-Chain Fatty Acid Production
The ISME Journal (2018) 12, 610–622 © 2018 International Society for Microbial Ecology All rights reserved 1751-7362/18 www.nature.com/ismej ORIGINAL ARTICLE Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production Nicole Reichardt1,2, Maren Vollmer1, Grietje Holtrop3, Freda M Farquharson1, Daniel Wefers4, Mirko Bunzel4, Sylvia H Duncan1, Janice E Drew1, Lynda M Williams1, Graeme Milligan2, Thomas Preston5, Douglas Morrison5, Harry J Flint1 and Petra Louis1 1The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, UK; 2Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 3Biomathematics and Statistics Scotland, Foresterhill, Aberdeen, UK; 4Department of Food Chemistry and Phytochemistry, Karlsruhe Institute of Technology (KIT), Adenauerring 20A, Karlsruhe, Germany and 5Scottish Universities Environmental Research Centre, University of Glasgow, Rankine Avenue, East Kilbride, UK The diet provides carbohydrates that are non-digestible in the upper gut and are major carbon and energy sources for the microbial community in the lower intestine, supporting a complex metabolic network. Fermentation produces the short-chain fatty acids (SCFAs) acetate, propionate and butyrate, which have health-promoting effects for the human host. Here we investigated microbial community changes and SCFA production during in vitro batch incubations of 15 different non-digestible carbohydrates, at two initial pH values with faecal microbiota from three different human donors. To investigate temporal stability and reproducibility, a further experiment was performed 1 year later with four of the carbohydrates. The lower pH (5.5) led to higher butyrate and the higher pH (6.5) to more propionate production. -
The Food Lawyers® Respectfully Request That FDA Implements the Following
December 7, 2020 Dockets Management Staff (HFA-305) Filed Electronically Food and Drug Administration https://www.regulations.gov Re: Sugars Metabolized Differently than Traditional Sugars (FDA-2020-N-1359) Ladies and Gentlemen: One Page Executive Summary FDA’s seeks information to “… promote the public health and help consumers make informed dietary decisions” regarding sugars that are metabolized differently than traditional sugars. Given the nation’s battles with diabetes and obesity, and the benefits that non-traditional sugars can offer in these battles, the Agency’s stated public policy goal goes to the very heart of American consumers’ health. This laudatory public policy’s realization is complicated by a lack of consumer awareness of how some sugars are metabolized differently than others. In an effort to answer the questions posed by the Agency regarding the treatment of Sugars that Are Metabolized Differently Than Traditional Sugars, we suggest that the Agency adapt a mechanism that will seek to harmonize the public policy of promoting public health with consumers’ lack of awareness of sugars that are metabolized differently than sucrose. In particular, we suggest that FDA should consider the following: 1. Establish a new category of sugars called Rare Sugars that exhibit the following characteristics: a. Are naturally occurring b. Impart a sweet taste that is at least 50% the sweetness of sucrose c. 2.0 kcal/g or less. d. Resulting pH of 6.0 or greater of dental plaque after consumption. e. No or low glycemic response. f. No or low insulinemic response. 2. Exclude Rare Sugars from “Total Sugars” and “Added Sugars” declarations to stimulate their deployment by industry and consumption by the public.